Relieves coughs and upper respiratory symptoms, including nasal congestion, associated…. ANDA 200963, held by Amneal Pharms. Codeine Phosphate; Phenylephrine Hydrochloride; Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 200963 (Promethazine Hydrochloride,Phenylephrine Hydrochloride W/Codeine Phosphate), held by Amneal Pharms, was first approved by FDA on Aug 26, 2015, with 7 approved supplements and 0 published complete response letters.
Promethazine and Phenylephrine HCl and Codeine Phosphate Oral Solution is indicated for the temporary relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold in patients 18 years of age and older. Limitations of Use Not indicated for pediatric patients under 18 years of age. Contraindicated in pediatric patients under 12 years of age. Contraindicated in pediatric patients 12 to 18 years of age after tonsillectomy or adenoidectomy.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 26, 2015 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Promethazine Hydrochloride,Phenylephrine Hydrochloride W/Codeine Phosphate10MG/5ML;5MG/5ML;6.25MG/5ML · syrup;oral | Codeine Phosphate; Phenylephrine Hydrochloride; Promethazine Hydrochloride | Rx |
| Dec 22, 2025 | Supplement 13Labeling · Standard review | Approved | None posted |
| Dec 22, 2025 | Supplement 12Labeling · Standard review | Approved | None posted |
| Dec 15, 2023 | Supplement 11Labeling · Standard review | Approved | None posted |
| Jun 28, 2018 | Supplement 5Labeling · Standard review | Approved | None posted |
| Jun 8, 2018 | Supplement 3Labeling · Standard review | Approved | None posted |
| Aug 29, 2017 | Supplement 2Labeling · Standard review | Approved | None posted |
| Jan 13, 2017 | Supplement 1Labeling · Standard review | Approved | None posted |
| Aug 26, 2015 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters